4.7 Article

Microbiome in Behcet?s syndrome

Related references

Note: Only part of the references are listed.
Review Rheumatology

Vascular Behcet syndrome: from pathogenesis to treatment

Alessandra Bettiol et al.

Summary: Behçet syndrome is a rare chronic inflammatory disease with unknown causes, commonly characterized by mucocutaneous and ocular symptoms. Vascular involvement, including both venous and arterial thrombosis, is a unique feature of this syndrome. The pathogenesis involves impaired immune-inflammatory response and neutrophil-mediated mechanisms leading to thrombogenesis. Treatment primarily focuses on immunosuppressants rather than anticoagulation.

NATURE REVIEWS RHEUMATOLOGY (2023)

Review Pharmacology & Pharmacy

Interactions between NSAIDs, opioids and the gut microbiota- Future perspectives in the management of inflammation and pain

Zoltan S. Zadori et al.

Summary: The composition of intestinal microbiota can be affected by medications such as NSAIDs and opioids, leading to dysbiosis. The underlying mechanisms of dysbiosis caused by these drugs are not well understood, but mucosal inflammation, changes in motility and pH, and direct drug effect on bacterial growth are possible contributors. The microbiota signatures of NSAIDs and opioids overlap with certain diseases like SpA, RA, and neuropathic pain in T2D. Drug-induced dysbiosis may contribute to the persistence of these diseases and limit the therapeutic effect of these medications. Probiotic supplementation and fecal microbiota transplantation may have an impact on the therapeutic efficacy of NSAIDs and opioids in these diseases.

PHARMACOLOGY & THERAPEUTICS (2023)

Review Immunology

The impact of the gut microbiome on extra-intestinal autoimmune diseases

Eiji Miyauchi et al.

Summary: The prevalence of autoimmune diseases has increased rapidly worldwide. Besides traditional risk factors, alterations in gut microbiota have been identified as important factors influencing autoimmune responses and disease outcome in extra-intestinal autoimmune diseases.

NATURE REVIEWS IMMUNOLOGY (2023)

Article Rheumatology

A unique circulating miRNA profile highlights thrombo-inflammation in Behcet's syndrome

Giacomo Emmi et al.

Summary: The study identified 29 deregulated human ci-miRNAs in BS patients, which clearly distinguished patients from controls. Further validation confirmed the dysregulation of miR-224-5p, miR-206, and miR-653-5p. ROC curve analyses showed that these ci-miRNAs can discriminate BS from healthy controls, active from inactive disease, as well as differentiate BS from patients with SLE and GCA.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Review Endocrinology & Metabolism

Gut barrier disruption and chronic disease

Jan Martel et al.

Summary: This article discusses the protective role of the intestinal barrier against gut microbes, food antigens, and toxins, as well as key factors associated with disease development and inflammation. In addition to known intestinal diseases, recent research indicates that intestinal barrier and microbiota dysbiosis may be closely linked to the development of metabolic, autoimmune, and aging-related disorders.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2022)

Review Immunology

Gut microbiome and autoimmune disorders

Walaa Abdelaty Shaheen et al.

Summary: Autoimmune diseases are caused by dysregulated immune systems and environmental triggers in genetically predisposed individuals. The gut microbiome acts as an intermediary between external environmental factors and the immune system, programming it to be tolerant to harmless antigens. However, when the gut microbiota is disrupted, the immune system can be directed towards pro-inflammatory pathways, leading to autoimmune diseases.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2022)

Review Immunology

Findings on the Relationship Between Intestinal Microbiome and Vasculitis

Boyuan Sun et al.

Summary: The microbiome of vasculitis patients is often characterized by dysbiosis, with altered microbial diversity and abundance compared to other diseases and healthy individuals. Treatment has been shown to improve or resolve dysbiosis in longitudinal studies. Animal models have also identified molecular changes in intestinal permeability and immune response.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Review Immunology

Gut Microbiota, Leaky Gut, and Autoimmune Diseases

Anna Christovich et al.

Summary: With the increasing prevalence of autoimmune diseases, the role of the gut microbiota as an environmental factor in disease development has become a major focus of research. Recent advances suggest a connection and potential cause-effect relationship between the gut microbiota and the onset or exacerbation of autoimmune diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults

Amanda M. Fretts et al.

Summary: Plasma concentrations of trimethylamine N-oxide (TMAO) and related metabolites are positively associated with the risk of death among older adults.

JAMA NETWORK OPEN (2022)

Article Cell Biology

Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum

Meagan E. Chriswell et al.

Summary: This study demonstrates a mechanism of rheumatoid arthritis (RA) pathogenesis through which a specific intestinal strain of bacteria can drive systemic autoantibody generation and joint-centered antibody deposition and immune activation.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Cell Biology

Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation

J. Casper Swarte et al.

Summary: This study analyzed fecal samples from liver and kidney transplant recipients and found that dysbiosis of the gut microbiome is associated with decreased survival rates after transplantation, as well as the use of immunosuppressive drugs. This research provides a foundation for potential microbiome-targeted interventions that could impact the outcomes of solid organ transplantation recipients.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Multidisciplinary Sciences

Hydrogen sulfide toxicity in the gut environment: Meta-analysis of sulfate-reducing and lactic acid bacteria in inflammatory processes

Dani Dordevic et al.

Summary: The review explores the impact of hydrogen sulfide on gut environment and microbiota, with a focus on sulfate-reducing bacteria and lactic acid bacteria. Through meta-analysis, it is found that lactic acid bacteria have more pronounced inhibitory effects on inflammatory bowel diseases, providing potential for further confirmations in future studies.

JOURNAL OF ADVANCED RESEARCH (2021)

Review Gastroenterology & Hepatology

Gut Microbiota-driven Drug Metabolism in Inflammatory Bowel Disease

Femke Crouwel et al.

Summary: This study reviewed the literature on microbial drug metabolism of medication prescribed in inflammatory bowel disease (IBD) practice, finding that gut microbiota can influence the metabolism of specific drugs used for IBD. The impact includes cleaving azo-bonds, metabolization of methotrexate, and conversion of thioguanine by intestinal bacteria.

JOURNAL OF CROHNS & COLITIS (2021)

Article Microbiology

Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease

Jason M. Shapiro et al.

Summary: The immunopathogenesis of inflammatory bowel disease (IBD) is linked to host genetics and intestinal dysbiosis. Investigating IgA responses to microbiota can reveal potential disease-modifying taxa and improved biomarkers of clinical course in IBD.

CELL HOST & MICROBE (2021)

Letter Cardiac & Cardiovascular Systems

Butyrate-Rich Diets Improve Redox Status and Fibrin Lysis in Behcet's Syndrome

Giacomo Emmi et al.

CIRCULATION RESEARCH (2021)

Article Immunology

Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behcet's syndrome

Alessandra Bettiol et al.

Summary: Behcet's syndrome (BS) is a systemic vasculitis with various clinical manifestations, where neutrophil hyperactivation plays a key role in pathogenesis. NETs and intracellular ROS production were found to be significantly increased in active non-vascular BS patients. Colchicine showed potential in reducing oxidation-induced damage by counteracting neutrophils-mediated mechanisms, indicating a possible therapeutic effect in BS.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

Article Immunology

Vedolizumab for the Management of Refractory Behcet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease

Marta Arbrile et al.

Summary: When conventional immunosuppressive drugs and anti-TNF-alpha agents fail in treating BD, vedolizumab (VDZ) may be a valid option, especially for cases with intestinal involvement.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Behcet's Disease-Do Microbiomes and Genetics Collaborate in Pathogenesis?

Nafeesa Mehmood et al.

Summary: Behcet's disease is a multisystem autoinflammatory condition with a genetic basis and dysbiosis of oral and gut microbiomes. Genetic polymorphisms in genes encoding molecules involved in gut biology may be linked to changes seen in microbiome studies, and a potential therapy for BD may involve an increase in bacterial species producing short chain fatty acids.

FRONTIERS IN IMMUNOLOGY (2021)

Article Microbiology

Alteration of the Fecal but Not Salivary Microbiome in Patients with Behcet's Disease According to Disease Activity Shift

Jin Cheol Kim et al.

Summary: The study revealed a correlation between the composition of microbiome in Behcet's disease patients and disease activity and symptoms, suggesting a potential role of gut microbiome in the pathogenesis of BD. Active BD patients showed distinct fecal microbiome composition compared to inactive patients and healthy controls.

MICROORGANISMS (2021)

Article Medicine, General & Internal

Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes The Cardiovascular Health Study

Rozenn N. Lemaitre et al.

Summary: In this study with 4442 participants, plasma concentrations of TMAO and related metabolites were not associated with incident type 2 diabetes. However, elevated concentrations of TMAO, carnitine, crotonobetaine, and gamma-butyrobetaine were linked to increased fasting insulin levels, indicative of insulin resistance, while betaine and choline were associated with decreased fasting insulin levels and improved insulin sensitivity.

JAMA NETWORK OPEN (2021)

Article Immunology

Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83

S. M. Shamsul Islam et al.

Summary: The study aimed to investigate the effect of Eubacterium rectale administration on DC activation and systemic inflammation in HSV-1-induced Behcet's disease. Results showed that E. rectale reduced the frequency of CD83+ cells and increased NK1.1+ cells in BD mice, improving symptoms. Co-administration of colchicine and E. rectale also decreased the frequency of CD83+ cells, suggesting E. rectale as a potential therapeutic adjuvant for BD management.

FRONTIERS IN IMMUNOLOGY (2021)

Article Rheumatology

Cluster analysis of phenotypes of patients with Behcet's syndrome: a large cohort study from a referral center in China

Jun Zou et al.

Summary: Behcet's syndrome (BS) is a complex disorder with debated subgroup classification. This study in China confirmed sex differences in BS phenotype and identified gastrointestinal, uveitis, and cardiovascular involvement clusters separately. Further research is needed to replicate and clarify the patterns of phenotype in BS.

ARTHRITIS RESEARCH & THERAPY (2021)

Article Rheumatology

Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behcet's disease in Japan

Yutaro Soejima et al.

Summary: This study identified five independent clinical clusters among BD patients in Japan and found that the proportion of each cluster varied over time. The five clusters are mucocutaneous, mucocutaneous with arthritis, neuro, GI, and eye. Recent phenotypical evolutions of BD in Japan were associated with changing proportions of these clinical clusters.

ARTHRITIS RESEARCH & THERAPY (2021)

Letter Gastroenterology & Hepatology

Global disparities in faecal microbiota transplantation research

Scott W. Olesen et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Biochemistry & Molecular Biology

A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors

Ina Nemet et al.

Article Immunology

Efficacy of the anti-IL 17 secukinumab in refractory Behcet's syndrome: A preliminary study

Gerardo Di Scala et al.

JOURNAL OF AUTOIMMUNITY (2019)

Review Pharmacology & Pharmacy

Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?

Anukriti Sharma et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Review Immunology

Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils

Giacomo Emmi et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Immunology

Behcet's Disease: An Overview of Etiopathogenesis

Pietro Leccese et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Food Science & Technology

Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications

Dorna Davani-Davari et al.

FOODS (2019)

Review Biochemistry & Molecular Biology

Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome

Ziying Zhang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)

Article Medicine, General & Internal

Synbiotic Supplementation May Relieve Anterior Uveitis, an Ocular Manifestation in Behcet's Syndrome

Gholamreza Askari et al.

AMERICAN JOURNAL OF CASE REPORTS (2019)

Article Biotechnology & Applied Microbiology

Probiotics and the Gut Immune System: Indirect Regulation

Giorgio La Fata et al.

PROBIOTICS AND ANTIMICROBIAL PROTEINS (2018)

Article Gastroenterology & Hepatology

Rediscover the clinical value of small intestinal bacterial overgrowth in patients with intestinal Behcet's disease

Jung Hyun Jo et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Biochemistry & Molecular Biology

Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential

Adam B. Roberts et al.

NATURE MEDICINE (2018)

Review Medicine, Research & Experimental

Influence of diet on the gut microbiome and implications for human health

Rasnik K. Singh et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2017)

Article Multidisciplinary Sciences

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

Mariana X. Byndloss et al.

SCIENCE (2017)

Review Medical Laboratory Technology

Microbiome, trimethylamine N-oxide, and CmssMark cardiometabolic disease

W. H. Wilson Tang et al.

TRANSLATIONAL RESEARCH (2017)

Article Biochemistry & Molecular Biology

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

Weifei Zhu et al.

Article Cardiac & Cardiovascular Systems

Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB

Marcus M. Seldin et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

Review Immunology

Regulation of immune cell function by short-chain fatty acids

Renan Oliveira Correa et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)

Review Immunology

Behcet's syndrome patients exhibit specific microbiome signature

Clarissa Consolandi et al.

AUTOIMMUNITY REVIEWS (2015)

Article Biochemistry & Molecular Biology

A biosynthetic pathway for a prominent class of microbiota-derived bile acids

A. Sloan Devlin et al.

NATURE CHEMICAL BIOLOGY (2015)

Review Biochemistry & Molecular Biology

Role of the Microbiota in Immunity and Inflammation

Yasmine Belkaid et al.

Article Multidisciplinary Sciences

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

Yukihiro Furusawa et al.

NATURE (2013)

Article Multidisciplinary Sciences

Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation

Jennifer L. Pluznick et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Multidisciplinary Sciences

Structure, function and diversity of the healthy human microbiome

Curtis Huttenhower et al.

NATURE (2012)

Review Cell Biology

Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR

Anna C. Calkin et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)

Article Multidisciplinary Sciences

Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme

Smaranda Craciun et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Multidisciplinary Sciences

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Zeneng Wang et al.

NATURE (2011)

Article Gastroenterology & Hepatology

Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response

Yan-Dong Wang et al.

HEPATOLOGY (2008)

Article Hematology

Farnesoid X receptor ligands inhibit vascular smooth muscle cell inflammation and migration

Yoyo T. Y. Li et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Review Cardiac & Cardiovascular Systems

Activation of platelet function through G protein-coupled receptors

Stefan Offermanns

CIRCULATION RESEARCH (2006)

Review Biochemistry & Molecular Biology

Bile salt biotransformations by human intestinal bacteria

JM Ridlon et al.

JOURNAL OF LIPID RESEARCH (2006)